Table
of Contents
|
|
|
|
Contributors |
vii |
|
Preface |
ix |
PART I |
PREDIABETES AND THE FHAGNOSIS OF DIABETES |
|
1 |
IS Prediabetes
a Risk Factor or is it a Disease? Kalpana
Muthusamy
and Adrian Vella |
3 |
2 |
Early
Diagnosis of Type 1 Diabetes: Useful or a Phyrrhic
Victory? Chiara Guglielmiand
Paolo Pozzilli |
11 |
3 |
How should
Secondary Causes of Diabetes be Excluded? Aonghus
O’Loughlin
and Sean F. Dinneen |
22 |
4 |
Screening
Patients with Prediabetes and Diabetes for Cardiovascular
Disease Deepika S. Reddy and Vivian Fonseca |
34 |
PART II |
INITIAL EVALUATION AND MANAGEMENT OF DIABETES |
|
5 |
What is the
Role of Self-Monitoring in Diabetes? is there a I Role for
Postprandial Glucose Monitoring? How does Continuous Glucose Monitoring
Integrate into Clinical Practice? Rami
Almokayyad
and Ruben Cuddihy |
43 |
6 |
The Optimal
Diet for Diabetes Is? Maria L. Collazo-Clavell |
56 |
7 |
How to
Determine When to Pursue Lifestyle Change Alone versus Pharmacotherapy at
Diagnosis? Galina Smushkin
and E John Service |
64 |
8 |
Insulin
Sensitizers versus Secretagogues as First-Line
Therapy for Diabetes: Rationale for Clinical Choice Robert
J. Richards, L Yvonne Melendez-Ramirez, and
William T. Cefalu |
71 |
9 |
Are Insulin
Sensilizers
Useful Additions to Insulin Therapy? John W. Richard III and Philip Raskin |
79 |
10 |
Is there a
Role for Incierin-Based Therapy in Combination with
Insulin? Matheni Sathananthan
and Adrian Vella |
91 |
11 |
Hba1c: is
it the Most Important Therapeutic Target in Outpatient Management of
Diabetes? Steven A.
Smith |
96 |
PART III |
MANAGEMENT OF ASSOCIATED RISK FACTORS AND DISEASE |
|
12 |
Primary
Therapy for Obesity as the Treatment of Type 2 Diabetes Manpreet
S. Mundi
and Michael D. Jensen |
107 |
13 |
Are Statins
the Optimal Therapy for Cardiovascular Risk in Patients with Diabetes? Are
Triglycerides an Important Independent Risk Factor for
Diabetes? Michael O’Reilly and Timothy O’Brien |
116 |
14 |
The Role of
Bariatric
Surgery in Obese Patients with Diabetes: Primary or Rescue
Therapy? Praveena Gandikota
and Blandine
Laferrère |
127 |
15 |
Hyperglycemia
should be Avoided in Critical Illness and the Postoperative
Period Kalpana Muthusamy
and John M. Miles |
134 |
16 |
Is there an
Optimal Revascularization Strategy in Diabetic Patients with Ischemic Heart
Disease? Stephen H.
McKellar,
Morgan L. Brown, and Robert L.
Frye |
145 |
|
Index |
153 |
|
|
|